Reversal of Botulinum Neurotoxin Injection Related Dysphonia With Pyridostigmine
Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effects of pyridostigmine (Mestinon) on patient
vocal outcomes after undergoing laryngeal botulinum neurotoxin (BoNT) injections, which is a
standard treatment for spasmodic dysphonia. Pyridostigmine (Mestinon) has been used for
treatment of BoNT overdose, and it is our hope that it will be beneficial in the management
of post BoNT breathy phase.